23AndMe wants to do more than showcase your family tree

23AndMe wants to do more than showcase your family tree


The home genetics company has teamed up with pharmaceutical giant GlaxoSmithKline to design new drugs that could treat diseases like Parkinson's, among others. Given 23andMe's substantial genetic database provided by its 5 million customers, the company hopes that a partnership with GSK could provide the necessary data to develop effective therapies.



from Biotech News